FTX United States Extradition Remains Unresolved, Bankman-Fried Still Imprisoned

The FTX United States extradition situation has hit an unexpected snag.
Sam Bankman-Fried (SBF), the one-time multibillionaire and disgraced FTX founder, appeared Monday morning (Dec. 19) before an emergency hearing of the Bahamas Magistrate Court. It was SBF’s first time back in court since his earlier request for a bail of just $250,000 and a notably lenient supervised home release was denied.
The hearing, which saw SBF’s lawyer, Jerome Roberts, tell the court he was not aware of his client’s plans, was adjourned with no ruling being given, meaning the crypto fraudster isn’t being extradited to the U.S. just yet.
Read more: How Sam Bankman-Fried Propped Up His Hollow Empire With Hype
There was reportedly confusion from the start, with SBF’s lawyer asking the judge why the emergency hearing was being held.
“Things are moving prematurely and without any involvement from me,” Roberts said.
Roberts has not immediately replied to a request by PYMNTS for comment. His client reportedly wishes to read his indictment before making a decision regarding extradition. SBF has apparently only seen the affidavit laying out the charges against him, as reported by Reuters.
SBF’s original extradition court trial was set for Feb. 8, although there is the potential one will be called for sooner given the chaos of Monday’s hearing.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas